| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM198403153101101 |
| P8608 | Fatcat ID | release_pszbaiqlzraovk6ty2rgkn6dxi |
| P698 | PubMed publication ID | 6700641 |
| P50 | author | Edward J. Filippone | Q71280409 |
| P2093 | author name string | Friedman EA | |
| Frank E | |||
| Landesman SH | |||
| Chen CK | |||
| Rao TK | |||
| Nicastri AD | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glomerulosclerosis | Q5571239 |
| P304 | page(s) | 669-673 | |
| P577 | publication date | 1984-03-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome | |
| P478 | volume | 310 |
| Q35858537 | A 20-year history of childhood HIV-associated nephropathy |
| Q38219256 | AIDS and autoimmunity |
| Q39628561 | AIDS presenting as focal segmental membranous glomerulopathy |
| Q73491880 | AIDS-associated membranous nephropathy with advanced renal failure: response to prednisone |
| Q44380731 | AIDS-related glomerulopathy: occurrence in specific risk groups |
| Q54580515 | APOBEC3G expression is restricted to epithelial cells of the proximal convoluted tubules and is not expressed in the glomeruli of macaques. |
| Q47432449 | APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated Nephropathy |
| Q27022275 | APOL1 and nephropathy progression in populations of African ancestry |
| Q58842232 | APOL1 risk variants and kidney disease: what we know so far |
| Q36509521 | Abdominal ultrasonography in HIV/AIDS patients in southwestern Nigeria |
| Q47108066 | Absence of HIV-Associated Nephropathy Among Antiretroviral Naive Adults With Persistent Albuminuria in Western Kenya |
| Q77895204 | Absence of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltration |
| Q39492711 | Acquired immune deficiency syndrome in childhood |
| Q38714643 | Acquired immunodeficiency syndrome (AIDS)--related renal disease |
| Q37940696 | Acquired immunodeficiency syndrome and renal disease: report of the National Kidney Foundation-National Institutes of Health Task Force on AIDS and Kidney Disease |
| Q37940693 | Acquired immunodeficiency syndrome and the kidney |
| Q68416870 | Acquired immunodeficiency syndrome-associated renal disease in children |
| Q37327049 | Acute kidney injury in HIV-infected patients |
| Q24243775 | Adjunctive therapies for HIV-associated nephropathy |
| Q40333751 | Adult-onset Still's disease associated with collapsing glomerulopathy |
| Q35596237 | Advances in our understanding of the pathogenesis of HIV-1 associated nephropathy in children |
| Q33415306 | Advances in the pathogenesis of HIV-associated kidney diseases |
| Q35567885 | African origins and chronic kidney disease susceptibility in the human immunodeficiency virus era. |
| Q57691243 | Angiotensin II provokes podocyte injury in murine model of HIV-associated nephropathy |
| Q43908453 | Anti-nuclear, anti-neutrophil cytoplasmic and anti-glomerular basement membrane antibodies in HIV-infected individuals |
| Q36795839 | Antiretroviral-treated HIV-infected women have similar long-term kidney function trajectories as HIV-uninfected women |
| Q35701311 | Apolipoprotein L1 (APOL1) Variants (Vs) a possible link between Heroin-associated Nephropathy (HAN) and HIV-associated Nephropathy (HIVAN) |
| Q68461230 | Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome |
| Q38774632 | Association of HIV infection with biomarkers of kidney injury and fibrosis in the Multicenter AIDS Cohort Study |
| Q38671545 | Autoimmunity and dysmetabolism of human acquired immunodeficiency syndrome |
| Q58797874 | Case of human immunodeficiency virus infection presenting as a tip variant of focal segmental glomerulosclerosis: A case report and review of the literature |
| Q64098161 | Challenges of kidney transplantation in HIV positive recipients |
| Q46486539 | Childhood AIDS nephropathy: a 10-year experience. |
| Q37024731 | Chronic kidney disease associated with perinatal HIV infection in children and adolescents |
| Q64106346 | Chronic kidney disease in patients infected with human immunodeficiency virus (HIV) in an urban cohort |
| Q41101233 | Cisplatin-Induced Nephrotoxicity and HIV Associated Nephropathy: Mimickers of Myeloma-Like Cast Nephropathy. |
| Q34736194 | Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America |
| Q57459177 | Collapsing glomerulopathy in older adults |
| Q40075366 | Collapsing glomerulopathy: a 30-year perspective and single, large center experience |
| Q72154567 | Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis |
| Q37386209 | Detection of HIV-1 RNA/DNA and CD4 mRNA in feces and urine from chronic HIV-1 infected subjects with and without anti-retroviral therapy |
| Q37119651 | Detection of human immunodeficiency virus type 1 (HIV-1) in urine cell pellets from HIV-1-seropositive individuals |
| Q35767643 | Determining the prevalence of human immunodeficiency virus-associated nephropathy (HIVAN) using proteinuria and ultrasound findings in a Nigerian paediatric HIV population. |
| Q40051440 | Diagnostic challenges of kidney diseases in HIV-infected patients. |
| Q38219884 | Differentiating HIV-associated nephropathy from antiretroviral drug-induced nephropathy: a clinical challenge |
| Q35833558 | Effects of human immunodeficiency virus sera and macrophage supernatants on mesangial cell proliferation and matrix synthesis. |
| Q33976064 | End-stage renal disease from human immunodeficiency virus–associated nephropathy in the United States, 2001 through 2010 |
| Q34686870 | Expert opinion on pharmacotherapy of kidney disease in HIV-infected patients |
| Q36728825 | Expression of HIV transgene aggravates kidney injury in diabetic mice |
| Q60142406 | Fibroblast growth factor-2 increases the renal recruitment and attachment of HIV-infected mononuclear cells to renal tubular epithelial cells |
| Q69836520 | Focal glomerulosclerosis with tubuloreticular inclusions: possible predictive value for acquired immunodeficiency syndrome (AIDS) |
| Q42821487 | Focal segmental glomerular sclerosis, a type of intractable chronic glomerulonephritis, is a stem cell disorder |
| Q37882019 | Focal segmental glomerulosclerosis after renal transplantation |
| Q33621421 | Gene-gene and gene-environment interactions in HIV-associated nephropathy: A focus on the MYH9 nephropathy susceptibility gene |
| Q34455119 | Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy |
| Q33821365 | Genetics of focal segmental glomerulosclerosis and human immunodeficiency virus-associated collapsing glomerulopathy: the role of MYH9 genetic variation |
| Q40566909 | Genitourinary manifestations of the acquired immunodeficiency syndrome |
| Q40465513 | Glomerular disease and lung transplantation |
| Q36987724 | Glomerular lesions in HIV-infected patients: a Yale University Department of Medicine Residency Peer-Teaching Conference |
| Q43525076 | Guidelines for the care of children and adolescents with HIV infection. Approach to the diagnosis and management of HIV-associated nephropathy |
| Q37602530 | HIV and kidney disease in sub-Saharan Africa |
| Q28069641 | HIV and kidney diseases: 35 years of history and consequences |
| Q36223766 | HIV and the kidney: a status report after 20 years |
| Q37073158 | HIV associated renal disease: a pilot study from north India |
| Q38447566 | HIV infection-induced transcriptional program in renal tubular epithelial cells activates a CXCR2-driven CD4+ T-cell chemotactic response |
| Q40978039 | HIV nephropathy in children. |
| Q33690345 | HIV-1 Vpr inhibits cytokinesis in human proximal tubule cells |
| Q53521281 | HIV-1 harboring renal tubular epithelial cell interaction with T cells results in T cell trans-infection. |
| Q93052655 | HIV-associated Immune Complex Kidney Disease with C3-dominant Deposition Induced by HIV Infection after Treatment of IgA Nephropathy |
| Q38702034 | HIV-associated immune complex kidney disease |
| Q72758262 | HIV-associated immune-mediated renal disease |
| Q38357279 | HIV-associated nephropathies: epidemiology, pathology, mechanisms and treatment |
| Q80083973 | HIV-associated nephropathy and end-stage renal disease in children in the United States |
| Q37302637 | HIV-associated nephropathy in Caucasians: case report and review of literature |
| Q42267516 | HIV-associated nephropathy in Saudi Arabia |
| Q45141182 | HIV-associated nephropathy in children |
| Q35110870 | HIV-associated nephropathy: Epidemiology, pathogenesis, and treatment |
| Q42348818 | HIV-associated nephropathy: a diagnosis in evolution |
| Q34657666 | HIV-associated nephropathy: clinical presentation, pathology, and epidemiology in the era of antiretroviral therapy |
| Q37202856 | HIV-associated nephropathy: epidemiology, pathogenesis, diagnosis and management |
| Q36223895 | HIV-associated renal disorders: recent insights into pathogenesis and treatment. |
| Q36453782 | HIV-related nephropathy: a South African perspective |
| Q37282295 | HIV-related renal disease and the utility of empiric therapy: not everyone needs to be biopsied |
| Q22306016 | Heroin-associated nephropathy |
| Q37980388 | How to manage HIV-infected patients with chronic kidney disease in the HAART era. |
| Q35130046 | Human Immunodeficiency Virus Infection in End‐Stage Renal Disease Patients |
| Q35138040 | Human immunodeficiency virus in the parturient |
| Q45868215 | Human immunodeficiency virus infection and nephrotic syndrome |
| Q34379788 | Human immunodeficiency virus infection and renal failure |
| Q40898362 | Human immunodeficiency virus nephropathy |
| Q35796282 | Human immunodeficiency virus-1 gp120 and gp160 envelope proteins modulate mesangial cell gelatinolytic activity |
| Q40415832 | Human immunodeficiency virus-associated glomerulosclerosis |
| Q80174151 | Human immunodeficiency virus-associated nephropathy |
| Q45402568 | Hypercalciuria is the main renal abnormality finding in Human Immunodeficiency Virus-infected children in Venezuela |
| Q41207128 | Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study |
| Q45857264 | IgA nephropathy in a child with human immunodeficiency virus type 1 infection |
| Q42982173 | Immune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus. |
| Q67283491 | Immune complexes in the acquired immunodeficiency syndrome (AIDS): relationship to disease manifestation, risk group, and immunologic defect |
| Q97645078 | Indirect effects of severe acute respiratory syndrome coronavirus 2 on the kidney in coronavirus disease patients |
| Q24201629 | Interventions for HIV-associated nephropathy |
| Q24240525 | Interventions for HIV-associated nephropathy |
| Q68928069 | Intestinal plasma cell alterations in acquired immunodeficiency syndrome |
| Q64938931 | Intrinsic tumor necrosis factor-α pathway is activated in a subset of patients with focal segmental glomerulosclerosis. |
| Q47943813 | Is dialysis modality a factor in survival of patients with ESRD and HIV-associated nephropathy? |
| Q45377385 | Is there a genetic basis for health disparities in human immunodeficiency virus disease? |
| Q38650645 | Kidney Disease in Human Immunodeficiency Virus-seropositive Patients: Absence of Human Immunodeficiency Virus-associated Nephropathy was a Characteristic Feature |
| Q37327066 | Kidney disease in HIV-positive children |
| Q36942310 | Kidney disease in children and adolescents with perinatal HIV-1 infection |
| Q91645910 | Liberation from Dialysis Dependence in a Patient with HIV-Associated Nephropathy (HIVAN) after Combined Antiretroviral Therapy (cART) |
| Q40893414 | Mechanisms of proteinuria in noninflammatory glomerular diseases |
| Q69446143 | Membranoproliferative glomerulonephritis and plexogenic pulmonary arteriopathy in a homosexual man with acquired immunodeficiency syndrome |
| Q38982416 | Minimal change disease and idiopathic FSGS: manifestations of the same disease. |
| Q41807560 | Minimal change nephropathy in the acquired immune deficiency syndrome. |
| Q39526492 | Modern management of nephrotic syndrome |
| Q34559775 | Modulation of renin angiotensin system predominantly alters sclerotic phenotype of glomeruli in HIVAN. |
| Q34650153 | Morphine induces albuminuria by compromising podocyte integrity |
| Q40865374 | Morphine stimulates mesangial cell TNF-alpha and nitrite production |
| Q36761283 | Multiple facets of HIV-associated renal disease |
| Q37452421 | Necrotizing arteritis in a human immunodeficiency virus-infected patient with lupus-like glomerulonephritis |
| Q38260894 | Nef as a Proliferative Factor for Kidney Epithelial Cells in HIV-Associated Nephropathy |
| Q39749405 | Neoplasia and glomerular injury |
| Q54285093 | Nephrotic syndrome associated with acquired immunodeficiency syndrome in children. |
| Q46178925 | Nephrotic syndrome, progressive irreversible renal failure, and glomerular "collapse": a new clinicopathologic entity? |
| Q30432292 | Outcomes of Kidney Transplantation in HIV-Infected Recipients |
| Q38639121 | Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis |
| Q24634681 | Pathogenesis of human immunodeficiency virus infection |
| Q38164170 | Pathogenesis of lentivirus infections |
| Q57997099 | Pathology of the Kidney in Childhood Immunodeficiency: Aids-Related Nephropathy is Not Unique |
| Q47567570 | Pharmacotherapy and treatment options for HIV-associated nephropathy. |
| Q36320626 | Pharmacotherapy for human immunodeficiency virus-associated nephropathy. |
| Q69859697 | Possible risk of steroid administration in patients at risk for AIDS |
| Q42483949 | Postmortem changes in the central nervous system and adrenal medulla of the heroin addicts |
| Q36435222 | Precipitable immune complexes in healthy homosexual men, acquired immune deficiency syndrome and the related lymphadenopathy syndrome |
| Q38198151 | Predictors of HIV-associated nephropathy |
| Q45769882 | Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy |
| Q35562175 | Presentation, pathology, and outcome of HIV associated renal disease in a specialist centre for HIV/AIDS |
| Q41201677 | Prevalence and Pattern of Chronic Kidney Disease in Antiretroviral-Naïve Patients with HIV/AIDS. |
| Q73740078 | Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients |
| Q43928866 | Prevalence of proteinuria in children followed-up for HIV infection at Pediatric University Hospital Charles-de-Gaulle (CHUP-CDG) of Ouagadougou |
| Q39749778 | Primary glomerular diseases (primary glomerulopathies). |
| Q36848421 | Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes |
| Q36504523 | Rapamycin-induced modulation of HIV gene transcription attenuates progression of HIVAN. |
| Q34000738 | Recurrent HIV-associated immune complex glomerulonephritis with lupus-like features after kidney transplantation |
| Q36162576 | Refinement of the HIVAN1 Susceptibility Locus on Chr. 3A1-A3 via Generation of Sub-Congenic Strains |
| Q39298252 | Renal Syndromes in the Acquired Immunodeficiency Syndrome (AIDS): Lessons Learned from Analysis Over 5 Years |
| Q83393590 | Renal Transplantation in HIV-Positive Recipients |
| Q34714716 | Renal abnormalities among HIV-infected, antiretroviral naive children, Harare, Zimbabwe: a cross-sectional study |
| Q41240990 | Renal complications in HIV disease |
| Q68253416 | Renal complications of acquired immunodeficiency syndrome in children |
| Q37937316 | Renal complications of human immunodeficiency virus type 1. |
| Q35561591 | Renal disease in HIV infected patients at University of Benin Teaching Hospital in Nigeria. |
| Q39719086 | Renal disease in an urban HIV population in the era prior and following the introduction of highly active antiretroviral therapy |
| Q36082342 | Renal disease in human immunodeficiency virus - Not just HIV-associated nephropathy |
| Q82430879 | Renal disease in patients with HIV |
| Q37154741 | Renal disease in patients with HIV infection: epidemiology, pathogenesis and management |
| Q34271639 | Renal diseases associated with human immunodeficiency virus infection: epidemiology, clinical course, and management |
| Q28539647 | Renal function in Ghanaian HIV-infected patients on highly active antiretroviral therapy: a case-control study |
| Q46878172 | Renal involvement in patients infected with HIV: experience at San Francisco General Hospital |
| Q52276741 | Renal pathology and HIV infection in Thailand. |
| Q38201325 | Renal transplantation in human immunodeficiency virus (HIV)-positive children |
| Q34079397 | Renal transplantation in patients with HIV. |
| Q35856080 | Renal ultrastructural markers in AIDS-associated nephropathy |
| Q44662684 | Research in HIV-related renal diseases lags behind their burden to the 'positive' community |
| Q33785277 | Rhesus macaques infected with macrophage-tropic simian immunodeficiency virus (SIVmacR71/17E) exhibit extensive focal segmental and global glomerulosclerosis |
| Q43443318 | Risk of HIV infection on patients and staff of two dialysis centers: seroepidemiological findings and prevention trends |
| Q28201539 | Role of 14-3-3epsilon, c-Myc/Max, and Akt phosphorylation in HIV-1 gp 120-induced mesangial cell proliferation |
| Q42443225 | Role of oxidative stress and heme oxygenase activity in morphine-induced glomerular epithelial cell growth |
| Q69989152 | Seborrheic-like dermatitis of acquired immunodeficiency syndrome. A clinicopathologic study |
| Q36113212 | Sequencing rare and common APOL1 coding variants to determine kidney disease risk |
| Q73491848 | Severity of AIDS and the response to EPO in uremia |
| Q69859574 | Short-term results with suramin for AIDS-related conditions |
| Q47548601 | Sonographic evaluation of kidney echogenicity and morphology among HIV sero-positive adults at Lagos University Teaching Hospital. |
| Q41161080 | Spectrum of Clinical Presentations in Human Immunodeficiency Virus (HIV) Infected Patients with Renal Disease. |
| Q46052783 | Spectrum of renal abnormalities in acquired immune-deficiency syndrome. |
| Q82482650 | Tackling the Unknowns in HIV-Related Kidney Diseases |
| Q37415434 | Taking a hard look at the pathogenesis of childhood HIV-associated nephropathy |
| Q34307868 | The New Epidemiology of HIV-Related Kidney Disease |
| Q42366694 | The Prevalence and Risk Factors of Renal Insufficiency among Korean HIV-Infected Patients: The Korea HIV/AIDS Cohort Study. |
| Q54964308 | The Role of MicroRNAs in Kidney Disease. |
| Q37763513 | The acute, the chronic and the news of HIV-related renal disease in Africa |
| Q38191448 | The changing epidemiology of HIV-related chronic kidney disease in the era of antiretroviral therapy. |
| Q45834291 | The clinical spectrum of renal disease associated with human immunodeficiency virus |
| Q61798506 | The effects of add-on corticosteroids on renal outcomes in patients with biopsy proven HIV associated nephropathy: a single centre study from South Africa |
| Q37827370 | The molecular pathogenesis of HIV-1 associated nephropathy: recent advances |
| Q40996604 | The primary glomerulopathies |
| Q37248150 | The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy |
| Q57736274 | The spectrum of renal histologies seen in HIV with outcomes, prognostic indicators and clinical correlations |
| Q33386834 | Thrombotic thrombocytopenic purpura with the acquired immunodeficiency syndrome: a pathologically documented case report |
| Q35603155 | Transforming growth factor-beta in disease: the dark side of tissue repair |
| Q37352087 | Treatment-dependent loss of polyfunctional CD8+ T-cell responses in HIV-infected kidney transplant recipients is associated with herpesvirus reactivation |
| Q43195821 | Trends in nephropathy among HIV-infected patients. |
| Q48915551 | Trends related to aging and co-occurring disorders in HIV-infected drug users |
| Q41048151 | Tubular cell and HIV-1 gp120 interaction products promote migration of monocytes |
| Q36910943 | Tubulointerstitial nephropathies in HIV-infected patients over the past 15 years: a clinico-pathological study |
| Q27691460 | Update on current management of chronic kidney disease in patients with HIV infection |
| Q45763852 | Uremia therapy in patients with end-stage renal disease and human immunodeficiency virus infection: has the outcome changed in the 1990s? |
| Q35188531 | Urinary NGAL is a useful clinical biomarker of HIV-associated nephropathy |
| Q37297688 | Urinary NGAL marks cystic disease in HIV-associated nephropathy. |
| Q37811483 | Urologic Aspects of HIV Infection |
| Q43678139 | Viral DNA in microdissected renal biopsy tissue from HIV infected patients with nephrotic syndrome |
| Q37114645 | Viral protein R of human immunodeficiency virus type-1 induces retrotransposition of long interspersed element-1. |
| Q43948298 | Virusassoziierte Glomerulonephritis |
| Q30238812 | What Do We Know about Opioids and the Kidney? |
| Q37093673 | mTOR plays a critical role in p53-induced oxidative kidney cell injury in HIVAN. |
Search more.